Chamber of Commerce Loses Bid to Challenge Medicare Drug Price Negotiation

The judge said the Chambers of Commerce ‘attempted to manipulate the system and manufacture standing to obtain a favorable venue.’

The U.S. Chamber of Commerce building in Washington on May 10, 2021. Andrew Kelly/Reuters

A federal district judge in Ohio on Thursday dismissed the U.S. Chamber of Commerce’s lawsuit challenging the constitutionality of a program that enables Medicare to negotiate prices with drugmakers for selected drugs.

The ruling named the Dayton Area Chamber of Commerce, the Ohio Chamber of Commerce, the Michigan Chamber of Commerce, and the U.S. Chamber of Commerce as plaintiffs in the case.